<DOC>
	<DOCNO>NCT00002255</DOCNO>
	<brief_summary>To evaluate safety , tolerance , biological activity filgrastim ( recombinant granulocyte colony stimulate factor ; G-CSF ) give daily subcutaneous injection prior concomitantly erythropoietin ( EPO ) zidovudine ( AZT ) patient AIDS severe ARC . To evaluate safety , tolerance , biological activity recombinant EPO give three time weekly subcutaneous injection concomitantly G-CSF prior concomitantly AZT patient AIDS severe ARC . To study safety tolerance three dose level AZT give concomitantly G-CSF EPO patient AIDS severe ARC . To study effect G-CSF neutrophil function number patient AIDS severe ARC . To study effect G-CSF alone combination EPO HIV replication vivo measure circulate HIV p24 antigen , plasma HIV viremia , semiquantitative HIV cocultures .</brief_summary>
	<brief_title>An Open-Label Phase I/II Study Recombinant Granulocyte Colony Stimulating Factor ( r-metHuG-CSF ) Recombinant Erythropoietin ( rHuEPO ) Given Subcutaneously Along With Zidovudine ( AZT ) Patients With Acquired Immune Deficiency Syndrome ( AIDS ) Severe AIDS-Related Complex ( ARC )</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>AIDS-Related Complex</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Ganciclovir ( DHPG ) treatment CMV infection . Concurrent Treatment : Allowed : Radiotherapy laser therapy Kaposi 's sarcoma lesion provide dose exceed 3000 rads one lesion group and/or great 10 cm total body surface area . Patients must : AIDS severe ARC . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Opportunistic infection require ongoing therapy know bone marrowsuppressive agent . ( Exception : patient may take ganciclovir treatment CMV infection . ) Evidence primary hematologic infectious disorder unrelated infection HIV virus . HIVrelated dementia alter mental status would prohibit informed consent . More 50 cutaneous Kaposi 's sarcoma lesion progression Kaposi 's sarcoma previous 30 day . Uncontrolled hypertension ( define diastolic great 100 mm Hg ) . Presence iron deficiency anemia define serum ferritin le 30 ng iron TIBC ration le 15 percent . Concurrent Medication : Excluded : Known bone marrowsuppressive agent trimethoprim / sulfamethoxazole Fansidar PCP prophylaxis . Any nonFDA approved agent may antiretroviral activity . Hyperimmunization polio virus , ribavirin , isoprinosine , dextran sulfate , fu zheng herb , AL 721 congener , imuthiol , interferon , chronic ( &gt; 10 day 30 day ) use Zovirax ( acyclovir ) , and/or &gt; 3 g/day oral vitamin C. Patients follow prior condition exclude : History malignancy Kaposi 's sarcoma . History cardiovascular disease seizure . Prior Medication : Excluded : Systemic cytotoxic chemotherapy within previous 4 week Kaposi 's sarcoma . Investigational drug within previous 4 week . Prior colony stimulate factor ( CSF ) . Any nonFDA approve drug within previous 2 week . Prior Treatment : Excluded : Radiotherapy within previous 4 week Kaposi 's sarcoma . Regular excessive use , currently within previous 3 month , alcohol hallucinogen psychotropic agent possibly addictive .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 1991</verification_date>
	<keyword>Erythropoietin</keyword>
	<keyword>Granulocyte Colony-Stimulating Factor</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
</DOC>